Having just published on Wednesday 8 April new guidelines to optimise the supply and availability of essential medicines during the COVID-19 pandemic, the European Commission is now sounding out Member States on the advisability of launching new common public procurement markets.
According to several sources, these new common public procurement contracts could concern investigational therapeutics, such as chloroquine, or new protective equipment, such as masks...